Digoxin NDC 17856-0057

NDC codes

FDA NDC Directory

Product NDC (as listed)17856-0057Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17856-0057Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
17856-0057-1	17856005701	2.5 mL in 1 CUP, UNIT-DOSE (17856-0057-1)Marketed from Dec 5, 2011
17856-0057-5	17856005705	5 mL in 1 CUP (17856-0057-5)Marketed from Sep 24, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Digoxin
Generic name (nonproprietary): digoxin
Active ingredients: Digoxin — .05 mg/mL
Dosage form: Solution
Route: Oral
Labeler: Atlantic Biologicals Corps
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021648
Marketing start: Aug 26, 2004
Listing expires: Dec 31, 2026
Other FDA classes: Cardiac Glycosides (Chemical structure)
Identifiers: Product ID 17856-0057_45b28de4-8c3d-5d99-e063-6294a90a9a95SPL ID 45b28de4-8c3d-5d99-e063-6294a90a9a95SPL set ID dcf907d9-0f0e-4ecc-a555-7e6dcc08c166RxCUI 393245UNII 73K4184T59
Pharmacologic class: Cardiac Glycoside

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N417856005701 followed by a unit qualifier and the quantity

Package 17856-0057-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 11, 2025.

Indications (excerpt from the label)

In adults, digoxin is indicated for the treatment of mild to moderate heart failure and for the control of resting ventricular rate in patients with chronic atrial fibrillation. (1) In pediatric patients with heart failure, digoxin increases myocardial contractility. 1.1 Heart Failure Digoxin Oral Solution, USP is indicated for the treatment of mild to moderate heart failure. Digoxin increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by increased exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, digoxin should be used with a diuretic and an angiotensin-conv…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 021648

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 021648
Product	Strength	Form · route	Labeler	Product NDC
Digoxin	Digoxin .05 mg/mL	SolutionOral	Hikma Pharmaceuticals USA Inc.	0054-0057